Abstract
In the recent few years, the emergence of heterocyclic ring-containing anti-cancer agents has gained a great deal of attention among medicinal chemists. Among these, azepine-based compounds are particularly becoming attractive recently. In this Focus Review, we highlight the recent advancements in the development of azepine-based anti-cancer compounds since the year 2000.
| Original language | English |
|---|---|
| Pages (from-to) | 539-557 |
| Number of pages | 19 |
| Journal | Anti-Cancer Agents in Medicinal Chemistry |
| Volume | 16 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2016 May 1 |
Bibliographical note
Publisher Copyright:© 2016 Bentham Science Publishers.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anticancer agents
- Azepane scaffold
- Chemotherapeutics
- Histone deacetylases
- Hormone modulators
- Kinase inhibitors
- Phototherapeutic agents
- Tubulin inhibitors
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology
- Cancer Research
Fingerprint
Dive into the research topics of 'Recent advances in anticancer chemotherapeutics based upon azepine scaffold'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS